Formulation: Advances in formulation development & manufacture for solid dosage, injectables, liquids & specialty dosage forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Formulation
Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

Week Of March 8, 2010: Company And People Notes: Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

March 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

Week Of March 1, 2010: Company And People Notes: Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

March 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

SMEDDS incorporated polymer matrix: A floating dosage form solution for drugs with poor gastric solubility

March 1, 2010

Pharmaceutical Technology Europe

A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.

Enhancing the bioavailability of poorly soluble drugs

March 1, 2010

Pharmaceutical Technology Europe

Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those companies seeking to reinvigorate marketed products.

Week Of Feb. 22, 2010: Company And People Notes: Merck To Eliminate 15,000 Jobs; Tauzin Stepping Down At PhRMA; And More.

February 25, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.

Week Of Feb. 15, 2010: Company And People Notes: Abbott Completes Acquisition Of Solvay; Merck Names President Of Consumer Healthcare; And More.

February 18, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.

Week Of Feb. 8, 2010: Company And People Notes: VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.

February 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.

Week of Feb. 1, 2010: Company and People Notes: Cephalon Buys Mepha; BASi's CEO Retires; and More.

February 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Cephalon Buys Mepha; BASi's CEO Retires; and More.

FDA Issues Draft Guidance on Drugs with Potential for Abuse

February 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration issued a draft guidance for industry, Assessment of Abuse Potential of Drugs, in late January.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
19%
In Western Europe
21%
In Central and Eastern Europe
3%
In Japan
2%
In India
28%
In China
27%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Click here